News - Stemnovate

Ruchi Sharma

20.10.2020

Stemnovate creates rapid diagnostic kit CE marked for professional use.

Stemnovate has released a £10 rapid diagnostic kit for the Covid-19 virus that it says will overcome the challenges of false results in testing.

The biotech company intends to manufacture the kits at Babraham Research Campus and is now seeking support to scale up the operation. Get more information here

Stemnovate creates rapid diagnostic kit ...

Stemnovate has released a £10 rapid dia...

Dr Ruchi Sharma on Tedx talk this Friday...

The future of healthcare depends on the ...

Stemnovate™ presents SARS CoV-2 -RDK- ...

Stemnovate has developed a rapid detecti...

Our CEO Ruchi Sharma, awarded top 21 to ...

The #21toWatch Top21.2020 were unveiled ...

Ruchi Sharma, CEO of Stemnovate nominate...

Out of hundreds of entries received, 246...

Stemnovate enables multi-organ drug scre...

Stemnovate is based in Cambridge and pro...

Stemnovate wins NC3R Grant to develop li...

Stemnovate, the Liver-on-chip pioneers, ...

14 innovative women in Cambridge leading...

Its annual report was followed by a summ...

Stem cell studies look toward producing ...

The Roslin Institute team is carrying ou...

$1 million funding for Cambridge ‘live...

Two Cambridge companies are feeling a mi...

Stem cell studies pave way to leaner liv...

A research partnership with industry is ...

Stemnovate nominated in Cambridge Indepe...

Stemnovate have been nominated in the th...

Stemnovate launch commercialised service...

We are delighted to announce the launch ...